Stock Comparison

ARGX vs BMRN

argenx NV ADR and Biomarin Pharmaceutical Inc side by side — valuation, profitability, growth and risk.

ARGX

argenx NV ADR

Healthcare

BMRN

Biomarin Pharmaceutical Inc

Healthcare

Valuation

Market Cap

$55.44B

$11.40B

P/E (TTM)

39.4

42.5

Forward P/E

34.0

11.9

Price/Sales

11.7

3.5

Price/Book

7.5

1.8

EV/EBITDA

33.9

22.0

Dividend Yield

—

Profitability

Net Margin

31.40%

8.29%

Operating Margin

30.00%

18.00%

Return on Equity

20.20%

4.48%

Return on Assets

8.86%

4.49%

Growth (YoY)

Revenue Growth

62.60%

2.80%

Earnings Growth

114.00%

-43.10%

Price & Risk

Beta

-0.0

0.2

52-Week High

$934.62

$66.28

52-Week Low

$510.06

$49.26

Analyst Target

$1,041.14

$87.85

Compare ARGX and BMRN your own way

Try mrmarket.ai free

Figures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.